title: A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4(+) T cells in mice.
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Sugiura
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Kageyama
authors.forename: Ayatoshi
authors.initials: A
authors.lastname: Andou
authors.forename: Tomoko
authors.initials: T
authors.lastname: Miyazawa
authors.forename: Chieko
authors.initials: C
authors.lastname: Ejima
authors.forename: Akira
authors.initials: A
authors.lastname: Nakayama
authors.forename: Taeko
authors.initials: T
authors.lastname: Dohi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Eda